“…One is based on the identification of molecular differences at the single-cell level, such as flow cytometry, fluorescence-activated cell sorting, next-generation proteomics, and lipidomic studies; − another is based on capturing or detecting single tumor cells from fresh or fixed primary tumors and metastatic tissues and rare circulating tumors cells (CTCs) from blood or bone marrow, for example, dielectrophoresis technique, microfluidic-based microposts chip, and electrochemical (EC) approach. Compared to other methods, EC sensors have the merits of easy operation, high sensitivity, and portability. − For example, a recent technique using rolling circle amplification with aptamers could successfully demonstrate a limit of detection (LOD) as low as 5 CTC cells in whole blood (with 200 μL of the sample used for incubation) . Another approach using quantum dots as sensing probe attained an LOD of 2 cells/mL in human serum .…”